Aurobindo’s Pediatric AIDS Combo Generic Approved; Eugia Restructuring Back On Cards
Anticipates Having Six To Seven Biosimilars In Regulated Markets By 2028
A US FDA tentative approval for Aurobindo’s dolutegravir combination generic for children should increase access under the PEPFAR program and aid sales. On a Q1 earnings call, renewed efforts to restructure Eugia, biosimilar launch plans and fallouts of oral drug shortages and damage to Pfizer’s US injectables warehouse were discussed.
